The Best of Both Worlds — Using Clinical Trial and Observational Data to Evaluate Vaccine Protection

Summary

Editorial perspective in NEJM discussing methodologies for evaluating vaccine protection using both clinical trial and observational data approaches. No specific drug candidates, company announcements, or material developments disclosed.